Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients

Abstract Background SETD2, the single mediator of trimethylation of histone 3 at position lysine 36, has been reported associated with initiation progression and chemotherapy resistance in acute myeloid leukemia (AML). Whether polymorphisms of SETD2 affect prognosis and chemotherapy response of AML...

Full description

Bibliographic Details
Main Authors:	Suwei Wang, Xiaoqing Yuan, Yazhen Liu, Kewei Zhu, Peng Chen, Han Yan, Daoyu Zhang, Xi Li, Hui Zeng, Xielan Zhao, Xiaoping Chen, Gan Zhou, Shan Cao
Format:	Article
Language:	English
Published:	BMC 2019-03-01
Series:	Journal of Translational Medicine
Subjects:	Acute myeloid leukemia SETD2 Histone 3 lysine 36 trimethylation SNP Chemotherapy Cytarabine
Online Access:	http://link.springer.com/article/10.1186/s12967-019-1848-9

Similar Items

Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia
by: Dávid Bajusz, et al.
Published: (2021-09-01)

Roles of SETD2 in Leukemia—Transcription, DNA-Damage, and Beyond
by: Anna Skucha, et al.
Published: (2019-02-01)

Histone Lysine Methyltransferase SETD2 Regulates Coronary Vascular Development in Embryonic Mouse Hearts
by: Fengling Chen, et al.
Published: (2021-04-01)

SETD2 mutations in primary central nervous system tumors
by: Angela N. Viaene, et al.
Published: (2018-11-01)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
by: Jiewen Sun, et al.
Published: (2020-11-01)

Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer
by: Jugang Wu, et al.
Published: (2020-06-01)

The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis
by: Min Liu, et al.
Published: (2021-07-01)

Histidine methyltransferase SETD3 methylates structurally diverse histidine mimics in actin
by: Andersen, S.B, et al.
Published: (2022)

Histone methyltransferase SETD1A participates in lung cancer progression
by: Mei Du, et al.
Published: (2021-08-01)

The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
by: Jacquelyn A. Myers, et al.
Published: (2020-03-01)

Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer
by: Jugang Wu, et al.
Published: (2021-06-01)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2−/− acute myeloid leukemia
by: Jiachun Song, et al.
Published: (2021-09-01)

Histone H3 Lysine 9 Methyltransferase DIM5 is required for the development and virulence of Botrytis cinerea
by: Xiaoli Zhang, et al.
Published: (2016-08-01)

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
by: Umma Habiba, et al.
Published: (2021-05-01)

The Methyltransferase Setd8 Is Essential for Erythroblast Survival and Maturation
by: Jeffrey Malik, et al.
Published: (2017-11-01)

SETD3 protein is the actin-specific histidine N-methyltransferase
by: Sebastian Kwiatkowski, et al.
Published: (2018-12-01)

The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia
by: Laura Monaghan, et al.
Published: (2019-08-01)

Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
by: Qiaoqiao Zhu, et al.
Published: (2019-05-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Characterization of Histone H3 Lysine 4 and 36 Tri-methylation in Brassica rapa L.
by: Hasan Mehraj, et al.
Published: (2021-06-01)

Assessment of oxidative stress in acute myeloid leukemia
by: Esfahani A, et al.
Published: (2011-02-01)

Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain
by: Qi An, et al.
Published: (2021-05-01)

Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells
by: Petra Otevřelová, et al.
Published: (2021-01-01)

Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C
by: Cong Cheng, et al.
Published: (2021-10-01)

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
by: Yasir Bashir, et al.
Published: (2015-01-01)

The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice
by: Kerstin Schmidt, et al.
Published: (2018-06-01)

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
by: Miku Wada, et al.
Published: (2020-12-01)

The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice
by: Seul Lee, et al.
Published: (2020-05-01)

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
by: Harinder Gill, et al.
Published: (2020-05-01)

Complete Trimethylation of Lysine Residues and its Application to the Quantitation of Lysine Methylation in Histones using Mass Spectrometry
by: Toth, Steven
Published: (2015)

Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
by: Axel H. Schönthal, et al.
Published: (2021-07-01)

Histone Lysine Methylation and Neurodevelopmental Disorders
by: Jeong-Hoon Kim, et al.
Published: (2017-06-01)

Análise de expressão de genes da família SETD em leucemia linfocítica crônica
by: Piazera, Flavia Zattar
Published: (2016)

TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE
by: Maël Heiblig, et al.
Published: (2016-01-01)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
by: Sook-Kyoung Heo, et al.
Published: (2020-12-01)

Role of CD19 and specific KIT‐D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities
by: Biao Wang, et al.
Published: (2021-02-01)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
by: Chen EC, et al.
Published: (2018-06-01)

SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 Transcription
by: Liu Yang, et al.
Published: (2020-06-01)

The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report
by: Abdullah M. Alrajhi, et al.
Published: (2019-10-01)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
by: Stefan Hatzl, et al.
Published: (2020-02-01)